Comments to FDA: PDUFA Share page: Docket Number: FDA-2010-N-0128 CHPA comments on proposed recommendations for the reauthorization of the Prescription Drug User Fee Act. Download Document Issues: OTC Medicines Monograph Reform Rx-to-OTC Switch User Fees Related Posts Press Releases and Statements West Virginia Expands Access to OTC Cold & Allergy Medications Containing PSE Mar 6, 2024 Press Releases and Statements CHPA Statement on Valisure Citizen Petition Mar 6, 2024 Summary of State Sales Tax Jun 1, 2018